Efficacy of S26308 against guinea pig cytomegalovirus infection.

Prophylactic use of antiviral agents against cytomegalovirus (CMV) is particularly indicated for the immunocompromised host because morbidity and mortality due to CMV occur most frequently following immunosuppression. We have evaluated the new Riker compound S26308 for its therapeutic and prophylact...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Chen, M, Griffith, B P, Lucia, H L, Hsiung, G D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1988
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172251/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2840014/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.5.678
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!